首页> 外文期刊>Endoscopy International Open >Percutaneous debridement and washout of walled-off abdominal abscess and necrosis using flexible endoscopy: a large single-center experience
【24h】

Percutaneous debridement and washout of walled-off abdominal abscess and necrosis using flexible endoscopy: a large single-center experience

机译:灵活的内窥镜经皮清创术清除壁上的腹部脓肿和坏死:大型单中心体验

获取原文
           

摘要

Background and study aims: Direct percutaneous endoscopic necrosectomy has been described as a minimally invasive intervention for the debridement of walled-off pancreatic necrosis (WOPN). In this retrospective cohort study, we aimed to confirm these findings in a US referral center and evaluate the clinical value of this modality in the treatment of pancreatic necrosis as well as other types of intra-abdominal fluid collections and necrosis. Patients and methods: Twelve consecutive patients with WOPN or other abdominal abscess requiring debridement and washout underwent computed tomography (CT)-guided drainage catheter placement. Each patient then underwent direct percutaneous endoscopic necrosectomy and washout with repeat debridement performed until complete. Drains were then removed once output fell below 30?mL/day and imaging confirmed resolution. The primary endpoints were time to clinical resolution and sustained resolution at 1-year follow up. Results: Ten patients were treated for WOPN, one for necrotic hepatic abscesses, and one for omental necrosis. The median time to intervention was 85 days with an average of 2.3 necrosectomies performed. Complete removal of drains was accomplished in 11 patients (92?%). The median time to resolution was 57 days. No serious adverse events occurred; however, one patient developed pancreaticocutaneous fistulas. Ten patients completed 1-year surveillance of which none required drain replacement. No patients required surgery or repeat endoscopy. Conclusions: This series supports the premise that direct percutaneous endoscopic necrosectomy is a safe and effective intervention for intra-abdominal fluid collections and necrosis in appropriately selected patients. Our study demonstrates a high clinical success rate with minimal adverse events. This modality offers several potential advantages over surgical and transgastric approaches including use of improved accessibility, an excellent safety profile, and requirement for only deep or moderate sedation.
机译:背景和研究目标:直接经皮内镜坏死切除术已被描述为清创性胰腺坏死(WOPN)的微创介入治疗。在这项回顾性队列研究中,我们旨在在美国转诊中心确认这些发现,并评估这种方式在治疗胰腺坏死以及其他类型的腹腔积液和坏死中的临床价值。患者和方法:连续十二名WOPN或其他需要清创和冲洗的腹部脓肿的患者接受计算机断层扫描(CT)引导的引流导管放置。然后对每位患者进行直接的经皮内镜下坏死切除术并冲洗,并重复清创术直至完成。一旦产量降至每天30?mL以下,并去除成像系统确认的分辨率,即可去除排水管。主要终点是达到临床缓解的时间以及在一年的随访中持续缓解的时间。结果:10例接受WOPN治疗,1例治疗坏死性肝脓肿,1例治疗大网膜坏死。干预的中位时间为85天,平均进行了2.3次肾切除术。 11名患者(92%)完全清除了引流管。解决问题的中位数时间为57天。没有发生严重的不良事件;但是,一名患者出现了胰皮肤瘘。十名患者完成了为期1年的监测,无一需要更换引流管。没有患者需要手术或重复内镜检查。结论:该系列产品支持的前提下,直接经皮内镜下坏死组织是腹腔内的积液及坏死适当选择病人安全和有效的干预。我们的研究表明,临床成功率高,不良事件少。与外科手术和经胃手术相比,这种方式具有若干潜在优势,包括使用改进的可及性,出色的安全性以及仅需要深度或中度镇静。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号